<DOC>
	<DOCNO>NCT01567774</DOCNO>
	<brief_summary>Patients coronary artery disease ( CAD ) often treat dual antiplatelet therapy ( DAT ) , include aspirin clopidogrel , prevent recurrent atherothrombotic event . Levels platelet reactivity patient DAT influence concomitant treatment medication inhibit CYP3A4 system involve activation clopidogrel . Atorvastatin simvastatin metabolize CYP3A4 [ Clin pharmacokinetic 2002 ; 41 : 343-70 ] , whereas cytochrome P450 mediate metabolism rosuvastatin appear minimal principally mediate 2C9 isoenzyme , little involvement CYP3A4 [ Clin Ther 2003 ; 25 : 2822-5. ] . Previous study compare atorvastatin versus rosuvastatin mean ex vivo platelet function test yield conflict result .</brief_summary>
	<brief_title>Pharmacodynamic Effects Atorvastatin vs. Rosuvastatin Platelet Reactivity</brief_title>
	<detailed_description>At least 1 month start DAT ( clopidogrel 75 mg aspirin 100 mg ) , patient receive randomly atorvastatin ( 20 mg day , N=50 ) rosuvastatin ( 10 mg bid , N=50 ) 30 day ( T-1 ) . At time-point , wash-out period 15 day first treatment atorvastatin rosuvastatin order avoid carry-over effect . Afterwards , cross-over perform , patient switch drug continue 30 day ( T-2 ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Angiographicallyproven coronary artery disease Class I indication DAT recent ( &lt; 12 month ) percutaneous coronary intervention and/or recent acute coronary syndrome ( &lt; 12 month ) Stable clinical condition Able understand willing sign inform CF Use drug interfere CYP activity proton pump inhibitor Women child bear potential patient must demonstrate negative pregnancy test perform within 24 hour CT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>dual antiplatelet therapy</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>rosuvastatin</keyword>
</DOC>